We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+6.41%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.42B
AUM Growth
+$84.1M
Cap. Flow
-$138M
Cap. Flow %
-3.12%
Top 10 Hldgs %
20.39%
Holding
706
New
62
Increased
172
Reduced
311
Closed
67

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$48.8M
2
V icon
Visa
V
+$40.8M
3
COST icon
Costco
COST
+$27M
4
DXC icon
DXC Technology
DXC
+$25.4M
5
GWW icon
W.W. Grainger
GWW
+$23.6M

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$29.2M
2
DIS icon
Walt Disney
DIS
+$22.7M
3
KMB icon
Kimberly-Clark
KMB
+$22.3M
4
SYY icon
Sysco
SYY
+$22M
5
CBRE icon
CBRE Group
CBRE
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Financials 13.82%
3 Healthcare 13.2%
4 Consumer Discretionary 10.87%
5 Industrials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SO icon
451
Southern Company
SO
$110B
$577K 0.01%
11,747
+4
+0% +$194
AGCO icon
452
AGCO
AGCO
$8.78B
$574K 0.01%
7,784
-75
-1% -$5.26K
WCN
453
Waste Connections
WCN
$42.8B
$574K 0.01%
8,208
NCLH icon
454
Norwegian Cruise Line
NCLH
$8.89B
$570K 0.01%
10,550
+2,515
+31% +$141K
KHC icon
455
Kraft Heinz
KHC
$30.4B
$565K 0.01%
7,281
-100
-1% -$8.36K
ATEN icon
456
A10 Networks
ATEN
$2.47B
$559K 0.01%
73,900
-11,615
-14% -$79.1K
CNC icon
457
Centene
CNC
$31.3B
$558K 0.01%
+11,524
New +$496K
COF icon
458
Capital One
COF
$124B
$553K 0.01%
6,528
-106,199
-94% -$8.75M
HON icon
459
Honeywell
HON
$77.1B
$553K 0.01%
4,318
TTD icon
460
Trade Desk
TTD
$8.13B
$553K 0.01%
89,950
-45,800
-34% -$248K
NVS icon
461
Novartis
NVS
$295B
$549K 0.01%
7,140
+4,263
+148% +$322K
IBDK
462
DELISTED
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
$549K 0.01%
21,920
-842
-4% -$21.1K
BUFF
463
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$546K 0.01%
19,270
-392,095
-95% -$9.6M
BAB icon
464
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$544K 0.01%
17,915
IPXL
465
DELISTED
Impax Laboratories, Inc.
IPXL
$543K 0.01%
+26,750
New +$511K
YELP icon
466
Yelp
YELP
$1.38B
$539K 0.01%
12,440
-2,940
-19% -$113K
VIXY icon
467
ProShares VIX Short-Term Futures ETF
VIXY
$211M
$538K 0.01%
207
+97
+88% +$299K
SYF icon
468
Synchrony
SYF
$23.7B
$528K 0.01%
17,010
-775
-4% -$23.2K
FDC
469
DELISTED
First Data Corporation
FDC
$525K 0.01%
29,104
+1,905
+7% +$34.8K
NKE icon
470
Nike
NKE
$61.9B
$523K 0.01%
10,081
-595
-6% -$33.4K
JAZZ icon
471
Jazz Pharmaceuticals
JAZZ
$15.9B
$518K 0.01%
3,540
MDLZ icon
472
Mondelez International
MDLZ
$77.7B
$518K 0.01%
12,751
-750
-6% -$31.8K
VCYT icon
473
Veracyte
VCYT
$4.52B
$517K 0.01%
58,910
+11,620
+25% +$94.5K
UPM
474
DELISTED
UPM-KYMMRME ADR (REPR ORD SHS)
UPM
$514K 0.01%
18,928
RDS.A
475
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$512K 0.01%
8,458

Similar funds

Boston Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Boston Advisors held 706 positions worth $4.42B, up 1.9% from $4.33B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Advisors withdrew a net $138M in Q3 2017, closing 67 positions and reducing 311 holdings. Its most notable exit was Pool Corp, an estimated $19.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Boston Advisors opened a new position in DXC Technology worth $26.6M.

  • Boston Advisors's largest Q3 2017 buy was DXC Technology: 358,536 shares worth $26.6M.
  • Boston Advisors added most to PepsiCo in Q3 2017, an estimated $48.8M increase.
  • Boston Advisors's biggest Q3 2017 reduction was Union Pacific, cutting an estimated $29.2M.
  • Boston Advisors fully exited Pool Corp in Q3 2017, selling an estimated $19.9M.
  • Boston Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q3 2017.
  • Boston Advisors opened 62 new positions and closed 67 in Q3 2017.
  • Boston Advisors's portfolio value rose 1.9% quarter-over-quarter to $4.42B.

Based on Boston Advisors's 13F filing for Q3 2017, filed 24 Oct 2017.